Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - thelancet.com
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …
被引用次数：120 相关文章

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez… - Lancet (London …, 2015 - europepmc.org
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - infona.pl
Incomplete revascularisation is common after percutaneous coronary intervention and is
associated with increased mortality and adverse cardiovascular events. We aimed to assess …

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - diva-portal.org
BACKGROUND: Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …
[PDF] his-files.com

[PDF][PDF] Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - 2015 - his-files.com
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …

[引用][C] Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - cir.nii.ac.jp
Ranolazine in patients with incomplete revascularisation after percutaneous coronary
intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial …
[PDF] his-files.com

[PDF][PDF] Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - 2015 - his-files.com
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The Lancet, 2016 - Elsevier
Background Incomplete revascularisation is common after percutaneous coronary
intervention and is associated with increased mortality and adverse cardiovascular events …

[引用][C] Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind …

G Weisz, P Généreux, A Iñiguez, A Zurakowski… - The …, 2016 - Elsevier Limited